Cite
APA Citation
Broekman, K., Jalving, M., van Tinteren, H., Sessa, C., & Reyners, A. (2018). clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer – ESMO-MCBS scores. Cancer treatment reviews, 69, 233–242. http://access.bl.uk/ark:/81055/vdc_100067809291.0x000032